Is it relevant to use an interleukin-1-inhibiting strategy for the treatment of patients with deficiency of interleukin-36 receptor antagonist?

被引：22
|
作者：
Tauber, M. [1 ,2 ]
Viguier, M. [2 ]
Le Gall, C. [1 ]
Smahi, A. [1 ]
Bachelez, H. [1 ,2 ]
机构：
[1] INSERM, Dept Genet, Imagine Inst, U781, F-75015 Paris, France
[2] Univ Paris Diderot, Hop St Louis, AP HP, Sorbonne Paris Cite,Dept Dermatol, Paris, France
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2014年 / 170卷 / 05期
关键词：
GENERALIZED PUSTULAR PSORIASIS; MUTATIONS; ANAKINRA; DISEASE;
D O I：
10.1111/bjd.12805
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1198 / 1199
页数：2
相关论文
共 50 条
  • [31] RETRACTED: Interleukin-36 receptor antagonist is associated with the progression of renal cell carcinoma (Retracted Article)
    Zhu, Kuangkuang
    Sun, Dong
    Zou, Xiaoqin
    Liu, Ruixia
    Wang, Zhen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 84
  • [32] Interleukin-36 receptor antagonist is activated by a neutrophil protease: implication for a regulatory role of neutrophils in psoriasis
    Doble, R.
    MacLeod, T.
    McGonagle, D.
    Stacey, M.
    Wittmann, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E152 - E152
  • [33] Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis
    Burden, A. David
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (05) : 473 - 481
  • [34] Homozygous IL36RN mutation and NSD1 duplication in a patient with severe pustular psoriasis and symptoms unrelated to deficiency of interleukin-36 receptor antagonist
    Carapito, R.
    Isidor, B.
    Guerouaz, N.
    Untrau, M.
    Radosavljevic, M.
    Launay, E.
    Cassagnau, E.
    Frenard, C.
    Aubert, H.
    Romefort, B.
    Le Caignec, C.
    Ott, L.
    Paul, N.
    Barbarot, S.
    Bahram, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (01) : 302 - 305
  • [35] Successful treatment of recalcitrant generalized pustular psoriasis in a young child with interleukin-36 receptor antagonist mutation with secukinumab monotherapy
    Albela, Henrietta
    Begum, Sabeera
    Leong, Kin Fon
    INDIAN JOURNAL OF PAEDIATRIC DERMATOLOGY, 2021, 22 (02) : 160 - 161
  • [36] Rapid response to secukinumab in a 5-year-old with deficiency of the interleukin-36 receptor antagonist (DITRA) with severe scalp and nail involvement
    Jing, Guo
    Bin, Wang
    Ying, Zhang Zhen
    PEDIATRIC DERMATOLOGY, 2021, 38 (05) : 1258 - 1263
  • [37] Neutrophil extracellular traps are induced in a psoriasis model of interleukin-36 receptor antagonist-deficient mice
    Soichiro Watanabe
    Yohei Iwata
    Hidehiko Fukushima
    Kenta Saito
    Yoshihito Tanaka
    Yurie Hasegawa
    Masashi Akiyama
    Kazumitsu Sugiura
    Scientific Reports, 10
  • [38] Neutrophil extracellular traps are induced in a psoriasis model of interleukin-36 receptor antagonist-deficient mice
    Watanabe, Soichiro
    Iwata, Yohei
    Fukushima, Hidehiko
    Saito, Kenta
    Tanaka, Yoshihito
    Hasegawa, Yurie
    Akiyama, Masashi
    Sugiura, Kazumitsu
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] Safety and Efficacy of Anakinra in Patients with Deficiency of Interleukin-1 Receptor Antagonist
    Montealegre, Gina A.
    de Jesus, Adriana Almeida
    Chapelle, Dawn C.
    Dancey, Paul
    Frenkel, Joost
    van Royen-Kerkhoff, Annet
    Herzog, Ronit
    Ciocca, Giovanna
    Rivas-Chacon, Rafael F.
    Reed, Ann M.
    Plass, Nicole
    Aksentijevich, Ivona
    Ferguson, Polly J.
    Hill, Suvimol C.
    Cowen, Edward
    Goldbach-Mansky, Raphaela T.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S861 - S861
  • [40] Deficiency of interleukin-1 receptor antagonist: A systematic review
    Barros, Wergila Ruana Gonsalves
    Gonsalves Junior, Jucier
    ARCHIVES OF RHEUMATOLOGY, 2024, 39 (04) : 566 - 578
12345